Govt panel approves Shionogi’s oral medicine for COVID-19
19:56 JST, November 22, 2022
The Health, Labor and Welfare Ministry’s meeting of experts on Tuesday decided to give emergency approval to Xocova, an oral medicine for COVID-19 developed by Shionogi & Co.
Xocova will become the country’s first domestically produced oral medicine for COVID-19 patients.
"Society" POPULAR ARTICLE
-
U.S. 7th Fleet officer Arrested on Suspicion of Stealing Sushi, Sashimi, Chicken at Kanagawa Shopping Mall; Suspect Caught Mid-Meal
-
JAL Airplane Experiences Radio Malfunction During Flight, Lands Safely By Relying on Light Signals
-
Cherry tree falls on man on Sanneizaka steps leading to famous Kiyomizu Temple in Kyoto
-
Earthquake in Western Japan a Reminder to Be Ready for the Big One; 14% of People Have Made No Preparations, Survey Says
-
Small Animal That Appears to be Mouse Found in Chojuku Bread Products; Some Brands on Same Production Line to be Recalled Voluntarily
JN ACCESS RANKING
- Weakening Yen Adds Complexity to BOJ’s Rate Hike Decisions; Rising Commodity Prices may Impact ‘Virtuous Cycle’ Efforts
- 70% of Japan Companies to Raise Pay Scales in FY 2024
- Core Consumer Prices Rise 2.8% in Fiscal 2023
- U.S. 7th Fleet officer Arrested on Suspicion of Stealing Sushi, Sashimi, Chicken at Kanagawa Shopping Mall; Suspect Caught Mid-Meal
- UNRWA Director Describes Catastrophic Destruction in Gaza; Says Relief Trucks Robbed, ‘People’s Hearts Destroyed’